BACKGROUNDPrimary hyperhidrosis (PH) can lead to mood changes due to the inconveniences it
causes.OBJECTIVEThis study aimed to examine the existence of anxiety and depression in patients
with severe primary hyperhidrosis who sought treatment at a medical office.METHODSThe questionnaire "Hospital Anxiety and Depression Scale" was used for 197
individuals, in addition to the chi square test and Fisher exact test, p
<0.05.RESULTSThere was an increased prevalence of anxiety (49.6%) but not of depression (11.2%)
among patients with PH, with no link to gender, age or amount of affected areas.
Palmar and plantar primary hyperhidrosis were the most frequent but when
associated with the presence of anxiety, the most frequent were the axillary (p =
0.02) and craniofacial (p = 0.02) forms. There was an association between patients
with depression and anxiety (p = 0.001).CONCLUSIONSthe involvement of Primary hyperhidrosis was responsible for a higher prevalence
of anxiety than that described among the general population and patients with
other chronic diseases. Depression had a low prevalence rate, while mild and
moderate forms were the most common and frequently associated with anxiety. The
degree of anxiety was higher in mild and moderate types than in the severe
form.
In the HUSE, the association of abdominal trauma with men under the influence of alcohol and illegal drugs was striking, reflecting the context of interpersonal violence in current society. Despite the magnitude of the traumas, the outcome was satisfactory, although deaths, occurred, demonstrating the importance of keeping a trained surgical team in emergency hospitals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.